Benefits Pro4h
Obesity drug cost crisis will end, Swiss Re analysts say
The current pain caused by the high cost of the GLP-1 agonist anti-obesity drugs will pass. Prachi Patkee and other analysts ...
Reuters13h
US FDA approves PTC Therapeutics' gene therapy for ultra-rare disorder
Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics ... Worldcategory Exclusive: Saudi Arabia ...
News Medical14h
The benefits and challenges of FDA Fast-Track and Accelerated Approval in drug development
Pharmaceutical companies can benefit from the FDA Fast Track and Accelerated Approval pathways by reducing the costs and time ...
Business Insider15h
BioSig Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
Our platform technology is addressing some of healthcare’s biggest challenges—saving time, saving costs, and saving lives. The Company’s FDA 510(k) cleared PURE EP™ Platform, provides superior, ...